StockWatch
·

Emcure Pharmaceuticals Ltd Q4 FY25 Results

EMCUREQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue2.1K7.8%
Total Income2.1K7.8%
Expenditure1.8K6.5%
PBT260.6113.3%
Net Profit197.2426.4%
OPM18.52%13.56pp
NPM9.30%1.36pp
EPS9.9722.8%
View full financials

Informational and educational content only. Not investment advice.